{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:19:56Z","timestamp":1740136796414,"version":"3.37.3"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>When our institution grew into an integrated multihospital health system, we were faced with the need to standardize laboratory processes, including blood bank processes, across all locations. The purpose of this article is to describe our experience of standardizing the protocols for prenatal testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>For each hospital in the system, we established service tiers to define tests offered on site or referred to another location. For each prenatal test, we examined the related processes for ways to improve uniformity, efficiency, and reliability. Throughout this process of standardization, we collaborated with the clinical services to gain concurrence on the interpretation and reporting of results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We created and implemented a uniform protocol for testing prenatal patients. The protocol standardized the definition of critical titer, instituted criteria to identify passively acquired anti-D, and established a process for the follow-up of women with inconsistent serologic results on Rh(D) typing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Close collaboration with the clinical services ensured that our testing protocol is aligned with the needs of the integrated obstetrics service in the health system. The approach described in this article may provide a plan outline for pathologists facing similar challenges at other integrated health systems.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ajcp\/aqaa120","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T19:24:22Z","timestamp":1593113062000},"page":"133-140","source":"Crossref","is-referenced-by-count":5,"title":["Implementation of a Standardized Prenatal Testing Protocol in an Integrated, Multihospital Health System"],"prefix":"10.1093","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2106-9704","authenticated-orcid":false,"given":"Suneeti","family":"Sapatnekar","sequence":"first","affiliation":[{"name":"Section of Transfusion Medicine, The Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Lu","sequence":"additional","affiliation":[{"name":"Section of Transfusion Medicine, The Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Bakdash","sequence":"additional","affiliation":[{"name":"Section of Transfusion Medicine, The Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NurJehan","family":"Quraishy","sequence":"additional","affiliation":[{"name":"Section of Transfusion Medicine, The Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"2021010403500525000_CIT0001","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"de Haas","year":"2015","journal-title":"Vox Sang."},{"key":"2021010403500525000_CIT0002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tmrv.2016.05.008","article-title":"Hemolytic disease of the fetus and newborn: modern practice and future investigations","volume":"30","author":"Hendrickson","year":"2016","journal-title":"Transfus Med Rev."},{"key":"2021010403500525000_CIT0003","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/trf.13977","article-title":"Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study","volume":"57","author":"Delaney","year":"2017","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0004","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1537-2995.2007.01625.x","article-title":"Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands","volume":"48","author":"Koelewijn","year":"2008","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.21307\/immunohematology-2019-134","article-title":"Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility","volume":"29","author":"Smith","year":"2013","journal-title":"Immunohematology."},{"key":"2021010403500525000_CIT0006","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/ije\/dyu079","article-title":"Associations of rhesus and non-rhesus maternal red blood cell alloimmunization with stillbirth and preterm birth","volume":"43","author":"Fan","year":"2014","journal-title":"Int J Epidemiol."},{"key":"2021010403500525000_CIT0007","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1701-2163(15)30148-1","article-title":"Alloimmune red blood cell antibodies: prevalence and pathogenicity in a Canadian prenatal population","volume":"37","author":"Zwingerman","year":"2015","journal-title":"J Obstet Gynaecol Can."},{"key":"2021010403500525000_CIT0008","doi-asserted-by":"crossref","first-page":"188","DOI":"10.21307\/immunohematology-2019-379","article-title":"Update on HDFN: new information on long-standing controversies","volume":"22","author":"Eder","year":"2006","journal-title":"Immunohematology."},{"key":"2021010403500525000_CIT0009","volume-title":"The Blood Group Antigen Factsbook","author":"Reid","year":"2012","edition":"3"},{"key":"2021010403500525000_CIT0010","article-title":"Perinatal issues in transfusion practice.","volume-title":"Technical Manual","author":"Delaney","year":"2017","edition":"19"},{"key":"2021010403500525000_CIT0011","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/AOG.0000000000002528","article-title":"ACOG Practice Bulletin Number 192: Management of alloimmunization during pregnancy","volume":"131","year":"2018","journal-title":"Obstet Gynecol."},{"key":"2021010403500525000_CIT0012","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200001063420102","article-title":"Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses","volume":"342","author":"Mari","year":"2000","journal-title":"N Engl J Med."},{"key":"2021010403500525000_CIT0013","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0966-3274(02)00065-5","article-title":"Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn","volume":"10","author":"Hadley","year":"2002","journal-title":"Transpl Immunol."},{"key":"2021010403500525000_CIT0014","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-3148.1995.tb00228.x","article-title":"Red cell antibodies in pregnancy: there is no \u2018critical titre\u2019","volume":"5","author":"van Dijk","year":"1995","journal-title":"Transfus Med."},{"key":"2021010403500525000_CIT0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-3148.2007.00816.x","article-title":"Haemolytic disease of the newborn presenting in a term baby born to a mother with negative red cell serology screening","volume":"18","author":"Joshi","year":"2008","journal-title":"Transfus Med."},{"key":"2021010403500525000_CIT0016","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/tme.12299","article-title":"Guideline for blood grouping and red cell antibody testing in pregnancy","volume":"26","author":"White","year":"2016","journal-title":"Transfus Med."},{"key":"2021010403500525000_CIT0017","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1067\/mob.2001.115999","article-title":"Management of isoimmunization in the presence of multiple maternal antibodies","volume":"185","author":"Spong","year":"2001","journal-title":"Am J Obstet Gynecol."},{"key":"2021010403500525000_CIT0018","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1537-2995.2009.02233.x","article-title":"Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities","volume":"49","author":"Nordvall","year":"2009","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0019","doi-asserted-by":"crossref","first-page":"68.e1","DOI":"10.1016\/j.ajog.2015.01.049","article-title":"Hemolytic disease of the fetus and newborn due to multiple maternal antibodies","volume":"213","author":"Markham","year":"2015","journal-title":"Am J Obstet Gynecol."},{"key":"2021010403500525000_CIT0020","doi-asserted-by":"crossref","DOI":"10.1111\/tme.12661","article-title":"Monitoring of prenatal patients using a combined antibody titre for Rh and non-Rh antibodies","author":"Farrell","year":"2020;30:210-214","journal-title":"Transfus Med."},{"key":"2021010403500525000_CIT0021","article-title":"Neonatal and pediatric transfusion practice.","volume-title":"Technical Manual","author":"Wong","year":"2017","edition":"19"},{"key":"2021010403500525000_CIT0022","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/tme.12145","article-title":"Red cell alloimmunisation following intrauterine transfusion and the feasibility of providing extended phenotype-matched red cell units","volume":"24","author":"Doyle","year":"2014","journal-title":"Transfus Med."},{"key":"2021010403500525000_CIT0023","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1111\/trf.13231","article-title":"Extended matched intrauterine transfusions reduce maternal Duffy, Kidd, and S antibody formation","volume":"55","author":"Schonewille","year":"2015","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0024","first-page":"175A","article-title":"Maternal alloimmunization during intrauterine transfusion: a reason for examining blood bank intrauterine transfusion policies","volume":"55","author":"Hudgins","year":"2015","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/vox.12302","article-title":"Interpretation of pretransfusion testing in obstetrical patients who have received antepartum Rh immunoglobulin prophylaxis","volume":"110","author":"Szkotak","year":"2016","journal-title":"Vox Sang."},{"key":"2021010403500525000_CIT0026","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/tme.12420","article-title":"Can serological methods help distinguish between prophylactic and alloimmune anti-D?","volume":"27","author":"Irving","year":"2017","journal-title":"Transfus Med."},{"key":"2021010403500525000_CIT0027","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/trf.13018","article-title":"Evaluation of different testing methods for identification of RhIG in red blood cell antibody detection","volume":"55","author":"Mikesell","year":"2015","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0028","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/trf.15631","article-title":"Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K-alloimmunized pregnancies","volume":"60","author":"Koelewijn","year":"2020","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0029","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/trf.12070","article-title":"Antibody of undetermined specificity: frequency, laboratory features, and natural history","volume":"53","author":"Liu","year":"2013","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0030","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.3109\/14767058.2015.1107540","article-title":"Non-specific red cell reactivity in an obstetric population","volume":"29","author":"Van Winden","year":"2016","journal-title":"J Matern Fetal Neonatal Med."},{"key":"2021010403500525000_CIT0031","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1423-0410.1982.tb00008.x","article-title":"Erythrocyte autoantibodies, autoimmune haemolysis and pregnancy","volume":"43","author":"Sokol","year":"1982","journal-title":"Vox Sang."},{"key":"2021010403500525000_CIT0032","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1046\/j.1537-2995.2001.41121559.x","article-title":"Increased RBC autoantibody production in pregnancy","volume":"41","author":"Hoppe","year":"2001","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0033","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000440672","article-title":"Harmless pregnancy-induced warm autoantibodies to red blood cells","volume":"42","author":"S\u00fcr\u00fcc\u00fc","year":"2015","journal-title":"Transfus Med Hemother."},{"key":"2021010403500525000_CIT0034","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/trf.12941","article-title":"It\u2019s time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group","volume":"55","author":"Sandler","year":"2015","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0035","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/j.1537-2995.2005.00586.x","article-title":"Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention","volume":"45","author":"Denomme","year":"2005","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0036","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1537-2995.1983.23283172867.x","article-title":"Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother","volume":"23","author":"Lacey","year":"1983","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0037","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/trf.14156","article-title":"Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn","volume":"57","author":"Quantock","year":"2017","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0038","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/AOG.0000000000002232","article-title":"ACOG Practice Bulletin number 181: prevention of Rh D alloimmunization","volume":"130","year":"2017","journal-title":"Obstet Gynecol."},{"key":"2021010403500525000_CIT0039","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1055\/s-0037-1607028","article-title":"Anti-M alloimmunization: management and outcome at a single institution","volume":"7","author":"Stetson","year":"2017","journal-title":"AJP Rep."},{"key":"2021010403500525000_CIT0040","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1537-2995.2007.01209.x","article-title":"Fetal hemolytic anemia and intrauterine death caused by anti-M immunization","volume":"47","author":"Wikman","year":"2007","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmrv.2013.10.002","article-title":"Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature","volume":"28","author":"Yasuda","year":"2014","journal-title":"Transfus Med Rev."},{"key":"2021010403500525000_CIT0042","article-title":"Anti-M antibodies as a cause of intrauterine fetal death and neonatal hyperbilirubinaemia","author":"Sharma","year":"2014;2014","journal-title":"BMJ Case Rep."},{"key":"2021010403500525000_CIT0043","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1097\/MPH.0000000000000341","article-title":"Anti-M antibody induced prolonged anemia following hemolytic disease of the newborn due to erythropoietic suppression in 2 siblings","volume":"37","author":"Ishida","year":"2015","journal-title":"J Pediatr Hematol Oncol."},{"key":"2021010403500525000_CIT0044","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.tjog.2017.04.022","article-title":"Prenatal treatment of severe fetal hemolytic disease due to anti-M alloimmunization by serial intrauterine transfusions","volume":"56","author":"Li","year":"2017","journal-title":"Taiwan J Obstet Gynecol."},{"key":"2021010403500525000_CIT0045","first-page":"73","article-title":"Anti-M induced severe haemolytic disease of foetus and newborn in a Malay woman with recurrent pregnancy loss","volume":"39","author":"Hassan","year":"2017","journal-title":"Malays J Pathol."},{"key":"2021010403500525000_CIT0046","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/trf.15054","article-title":"Hemolytic disease of the fetus and newborn due to alloanti-M: three Chinese case reports and a review of the literature","volume":"59","author":"Li","year":"2019","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0047","first-page":"1145","article-title":"Is a third-trimester antibody screen in Rh+ women necessary?","volume":"5","author":"Rothenberg","year":"1999","journal-title":"Am J Manag Care."},{"key":"2021010403500525000_CIT0048","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/j.1537-2995.2010.03006.x","article-title":"Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME)","volume":"51","author":"Dajak","year":"2011","journal-title":"Transfusion."},{"key":"2021010403500525000_CIT0049","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/1471-0528.13816","article-title":"Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme","volume":"123","author":"Slootweg","year":"2016","journal-title":"BJOG."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/155\/1\/133\/35373914\/aqaa120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/155\/1\/133\/35373914\/aqaa120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T23:08:24Z","timestamp":1696288104000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/155\/1\/133\/5901028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,9,3]]},"published-print":{"date-parts":[[2021,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqaa120","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"type":"print","value":"0002-9173"},{"type":"electronic","value":"1943-7722"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2020,9,3]]}}}